Managed Account Advisors’s Edwards Lifesciences EW Stock Holding History

Managed Account Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$13M	Buy	548,898 +478,572	+681%	+$10.8M	0.01%	957
2015 Q1	$1.67M	Sell	70,326 -47,568	-40%	-$1.07M	﹤0.01%	1925
2014 Q4	$2.5M	Buy	117,894 +89,286	+312%	+$1.79M	﹤0.01%	1721
2014 Q3	$487K	Sell	28,608 -24,312	-46%	-$384K	﹤0.01%	2181
2014 Q2	$757K	Sell	52,920 -14,802	-22%	-$201K	﹤0.01%	2070
2014 Q1	$837K	Sell	67,722 -2,868,276	-98%	-$33.1M	﹤0.01%	1999
2013 Q4	$32.2M	Sell	2,935,998 -328,818	-10%	-$3.71M	0.04%	455
2013 Q3	$37.9M	Sell	3,264,816 -5,482,182	-63%	-$64.1M	0.06%	376
2013 Q2	$98M	Buy	+8,746,998	New	+$104M	0.15%	162

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Managed Account Advisors's EW Position: Q2 2015 in Review

Managed Account Advisors increased its Edwards Lifesciences (EW) stake by 681% in Q2 2015, buying an estimated $10.8M and bringing the position to 548,898 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #957.

Managed Account Advisors first reported a position in EW in Q2 2013 and has held it in 9 quarters since. The position peaked at $98M in Q2 2013. 579 funds tracked by Wall St. Rank hold EW as of Q2 2015.

Managed Account Advisors held 548,898 shares of Edwards Lifesciences worth $13M as of Q2 2015.
Managed Account Advisors bought 478,572 Edwards Lifesciences shares in Q2 2015, an estimated $10.8M.
Edwards Lifesciences made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #957 holding.
Managed Account Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Edwards Lifesciences position peaked at $98M in Q2 2013.
579 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.